Literature DB >> 19033472

Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus.

Jörg Schröer1, Thomas Shenk.   

Abstract

Human cytomegalovirus has previously been shown to induce the accumulation of cyclooxygenase-2 RNA, protein, and enzyme activity. High doses of cyclooxygenase inhibitors substantially block viral replication in cultured fibroblasts. However, doses corresponding to the level of drug achieved in the plasma of patients have little effect on the replication of human cytomegalovirus in cultured cells. Here, we demonstrate that two nonsteroidal anti-inflammatory drugs, tolfenamic acid and indomethacin, markedly reduce direct cell-to-cell spread of human cytomegalovirus in cultured fibroblasts. The block is reversed by addition of prostaglandin E2, proving that it results from the action of the drugs on cyclooxygenase activity. Because direct cell-to-cell spread likely contributes importantly to pathogenesis of the virus, we suggest that nonsteroidal anti-inflammatory drugs might help to control human cytomegalovirus infections in conjunction with other anti-viral treatments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033472      PMCID: PMC2614784          DOI: 10.1073/pnas.0810740105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene.

Authors:  Dong Yu; Gregory A Smith; Lynn W Enquist; Thomas Shenk
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 2.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

3.  Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.

Authors:  Edmund S Ho; Deborah C Lin; Dirk B Mendel; Tomas Cihlar
Journal:  J Am Soc Nephrol       Date:  2000-03       Impact factor: 10.121

4.  Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

Authors:  G Gerna; E Percivalle; F Baldanti; S Sozzani; P Lanzarini; E Genini; D Lilleri; M G Revello
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs.

Authors:  E P Browne; B Wing; D Coleman; T Shenk
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome.

Authors:  C Sinzger; K Schmidt; J Knapp; M Kahl; R Beck; J Waldman; H Hebart; H Einsele; G Jahn
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

7.  Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread.

Authors:  D C Johnson; M Webb; T W Wisner; C Brunetti
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B.

Authors:  K A Simmen; J Singh; B G Luukkonen; M Lopper; A Bittner; N E Miller; M R Jackson; T Compton; K Früh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

9.  Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication.

Authors:  Hua Zhu; Jian-Ping Cong; Deborah Yu; Wade A Bresnahan; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

10.  Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

Authors:  Hermann Einsele; Eddy Roosnek; Nathalie Rufer; Christian Sinzger; Susanne Riegler; Jürgen Löffler; Ulrich Grigoleit; Arnaud Moris; Hans-Georg Rammensee; Lothar Kanz; Annette Kleihauer; Friederike Frank; Gerhard Jahn; Holger Hebart
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

View more
  25 in total

1.  Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs.

Authors:  Diwakar Santhakumar; Thorsten Forster; Nouf N Laqtom; Rennos Fragkoudis; Paul Dickinson; Cei Abreu-Goodger; Sergei A Manakov; Nila Roy Choudhury; Samantha J Griffiths; Annaleen Vermeulen; Anton J Enright; Bernadette Dutia; Alain Kohl; Peter Ghazal; Amy H Buck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

Review 2.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

3.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

4.  Human cytomegalovirus pUS27 G protein-coupled receptor homologue is required for efficient spread by the extracellular route but not for direct cell-to-cell spread.

Authors:  Christine M O'Connor; Thomas Shenk
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

5.  Estrogen-related receptor α is required for efficient human cytomegalovirus replication.

Authors:  Jesse Hwang; John G Purdy; Kai Wu; Joshua D Rabinowitz; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

6.  Human cytomegalovirus tegument protein pUL71 is required for efficient virion egress.

Authors:  Andrew Womack; Thomas Shenk
Journal:  mBio       Date:  2010-11-30       Impact factor: 7.867

7.  Human cytomegalovirus transcriptome activity differs during replication in human fibroblast, epithelial and astrocyte cell lines.

Authors:  James C Towler; Bahram Ebrahimi; Brian Lane; Andrew J Davison; Derrick J Dargan
Journal:  J Gen Virol       Date:  2012-01-18       Impact factor: 3.891

Review 8.  Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.

Authors:  Mary K McCarthy; Jason B Weinberg
Journal:  Mediators Inflamm       Date:  2012-05-15       Impact factor: 4.711

9.  Saturated very long chain fatty acids are required for the production of infectious human cytomegalovirus progeny.

Authors:  Emre Koyuncu; John G Purdy; Joshua D Rabinowitz; Thomas Shenk
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

10.  Histone Deacetylase Inhibitor SAHA Induces Expression of Fatty Acid-Binding Protein 4 and Inhibits Replication of Human Cytomegalovirus.

Authors:  Zhongshun Liu; Baoqin Xuan; Shubing Tang; Zhikang Qian
Journal:  Virol Sin       Date:  2021-06-22       Impact factor: 6.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.